Friday, 15 Nov 2019

Autoimmune/Lupus

Date Typesort ascending Title Save
15 Dec 2018 Social Bing Bingham MD talking on immune related adverse events (MSK and autoimmune). Says these occur in 3-5% of cancer pts treated with Checkpoint inhibitors. Unofficial surveys show nearly 50% of Rheums have seen these referrals. #MARS #ARTHROS https://t.co/yZHMQjpMz8
10 Jun 2015 Social Classification of inflamm aortitis based infiltration patterns seen in GCA, Takayasus, GPA, RA, Sarcoid, AS, infx http://t.co/n75S0FSZ9c
29 Feb 2016 Social Post. reversible encephalopathy (PRES) is rare in #SLE. ^Risk w/ HTN, CRI, Dz activity, lymphopenia, ^Lipids, youth https://t.co/QHFQREnIxA
10 Nov 2015 Social Check out video of Dr Peter Merkel on ANCA-Assoc Vaculitis from RheumNow. #ACR15. https://t.co/4pn5XAm4RV
19 Jan 2017 Social Israeli study shows Lupus has a 3 fold higher risk of cancer, esp NHL, Hodgkins, Mult myeloma, GU malignancies https://t.co/PgBYM35cza
29 Apr 2017 Social RT @DrRachelTate: Pearls on Scleromxyedema and scleredema from Dr. Hummers @RheumNow #SOTA2017 https://t.co/z7ZjJgtWhD
03 Jul 2015 Social NEJM reviews Jaccouds arthritis in lupus - reducible finger deformities, despite being seronegative for RF/CCP http://t.co/MZJyjnofIG
21 Mar 2016 Social Chugai received orphan drug approval status for tocilizumab in #scleroderma (JAPAN Only); phase II trial in progress https://t.co/NxmDOiEHEN
12 May 2016 Social Retrospective study from Brigham shows adverse SLE pregnancy outcomes assoc. w/ nephritis, cytopenia, serositis https://t.co/SYYTZQEbC2
16 Feb 2017 Social RT @DrRachelTate: Low dose IL-2 possible tx for SLE. #rwcs2017 @RWCSmtg @RheumNow https://t.co/de5cduW6v0
30 Apr 2017 Social RT @DrRachelTate: Current secondary thrombosis prevention targets for INR. Dr. Erkan @RheumNow #SOTA2017 https://t.co/zGKLxMLa3Q
25 May 2017 Social RT @AJKDonline: #OpenAccess Induction & Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Meta-Analysis https://t…
04 Nov 2017 Social RT @DrBhana: Lupus retinopathy #ACR17 https://t.co/qkuecgMHCk
07 Nov 2017 Social RT @philipcrobinson: Treatment of Sicca Syndrome of immune related adverse events to checkpoint inhibitors @RheumNow #ACR17 https://t.co/l0…
13 Jun 2018 Social 1349 SLE pts from Hopkins Lupus Cohort, had 398 pregnancies in 304 patients. Pregnancy associated with an increased flare rate (HR: 1.59); flare rates were less in those on hydroxychloroquine (HR 1.29 vs 1.86 off HCQ) https://t.co/spjj3x73aE
04 Oct 2018 Social 131 CTD Chinese pts with severe thrombocytopenia (P<20K) finds it mostly in Sjogrens (53%) & SLE (41%); 73% had bleeding, 37% resp to steroids or IVIG, another 22% responded to immunosuppressives.11 died; 8 from hemorrhage. Is this a Chinese Thing? https://t.co/aOlM1SvK93
13 Sep 2015 Social RT @SjogrensCa: Immune Components of Liver Damage Associated with Connective Tissue Diseases http://t.co/z5XlKc6TCA #sjogrens #rheum
02 Apr 2019 Social RT @MedReuma: Biologic Treatment of Giant Cell Arteritis. Paul Monach in #RNL2019 #vasculitis @RheumNow https://t.co/2iahcf1Vwp
29 Aug 2019 Social Among 312 Lupus patients, epilepsy seen in 36 (11.5%)- 30 had focal onset. Half had NPSLE. NPSLE + Epilepsy were more likely to have APS; and Cerebrovascular dz & psychosis were 2-3 fold higher (compare to NPSLE without epilepsy (p<0.001). https://t.co/jOb4WkbxL4
28 Oct 2016 Social Congrats to Dr Kerstin Nündel & U Mass;recipients of $500K grant from Lupus Res Alliance to study Bcells, TLR9, AXL https://t.co/feDmu9vmwd